CervoMed Inc. 8-K

What Happened
CervoMed Inc. (CRVO) filed a Form 8-K on March 17, 2026 to announce its financial results for the quarter and full year ended December 31, 2025. The company attached the press release reporting those results as Exhibit 99.1 to the 8-K. In addition, CervoMed posted a corporate presentation under Investors – Events and Presentations on its website and disclosed that representatives may use that presentation in investor conferences and meetings (Regulation FD disclosure).

Key Details

• Press release announcing quarter and full‑year 2025 results: attached as Exhibit 99.1 to the Form 8‑K (filed March 17, 2026).
• Reporting period: quarter and full year ended December 31, 2025.
• Presentation posted on www.cervomed.com under “Investors – Events and Presentations”; company may use this presentation, with possible non‑material edits, in investor communications.
• Form 8‑K includes the Inline XBRL cover page (interactive data file).

Why It Matters
This filing signals that CervoMed has published its latest earnings and financial condition information—key facts investors use to assess revenue, profitability, cash position, and progress against company guidance and clinical or business milestones. Retail investors should read the attached press release (Exhibit 99.1) and the posted presentation for the specific financial metrics and management commentary; those details will drive near‑term investor decisions and market reaction. The company notes it has no obligation to update the presentation except as required by law.